An observational study in Leukemia and Lymphoma, sponsored by Eastern Cooperative Oncology Group. Completed at 214 sites in United States. Open to participants aged 0 Years to 120 Years. Per ClinicalTrials.gov, last updated 2023-06-22.
Sponsored by Eastern Cooperative Oncology Group · Observational
RATIONALE: Collecting and storing samples of blood and bone marrow from patients with cancer to study in the laboratory may help doctors learn more about diagnosing cancer and determine a patient's eligibility for a treatment clinical trial. It may also help the study of cancer in the future.
PURPOSE: This laboratory study is collecting tissue samples from patients with leukemia or other blood disorders who are planning to enroll in an ECOG leukemia treatment clinical trial.
OBJECTIVES:
OUTLINE: This is a cohort, multicenter study.
Patients submit bone marrow and/or blood samples. The samples are studied to determine patients' eligibility for ECOG leukemia treatment clinical trials. Samples may be stored for future correlative studies related to ECOG treatment clinical trials.
5,578 studies on the registry are indexed under Lymphoma; 825 are open to participants now.
This study's enrollment of 1,873 is above the median of 136 across 625 observational studies indexed under Lymphoma.
Browse Lymphoma studies →Eastern Cooperative Oncology Group is the lead sponsor of 173 studies on the registry; 7 are open to participants now.
Of its 10 completed or terminated interventional studies of FDA-regulated products, 5 (50%) have results posted.
Counted across the registry records on this site, refreshed daily.
Potential candidates for ECOG-ACRIN Leukemia Trials
DISEASE CHARACTERISTICS:
Candidate for enrollment on an ECOG treatment clinical trial for acute or chronic leukemia
Chosen ECOG treatment clinical trial must be active and accruing
Patient may be concurrently enrolled on this laboratory study and a treatment clinical trial if immediate treatment is medically necessary
PATIENT CHARACTERISTICS:
PRIOR CONCURRENT THERAPY:
Providing a mechanism for sample collection and submission for diagnostic review to determine eligibility for enrollment on ECOG leukemia clinical trials
Time frame: 6 month
Obtaining baseline sample collection for correlative studies outlined in parent clinical trials
Time frame: 6 month
Showing the first 100 of 214 sites.
This study is completed, as verified in Jun 2023. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Eastern Cooperative Oncology Group